Advertisement
Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal
This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more
- Y-mAbs to Present at J.P. Morgan Healthcare Conference 2025 (2024-12-23)
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of canc... - Gilde HC Invests alongside Capital A in Tromp Medical (2024-12-16)
Tromp Medical, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new investor to drive further growth in the medical imaging market. Headquartered in the Netherlands, Tromp Medical specializes in instal... - 2cureX AB Appoints Dan Honeywell as CEO (2024-12-16)
2cureX AB (Nasdaq First North: 2CUREX) proudly announces the appointment of Dan Honeywell as Chief Executive Officer, marking a significant step forward in the company's mission to revolutionize cancer patient care through its pioneering IndiTreat® functional prec... - Darren Verlenden New CEO of Single Use Support (2024-12-16)
Single Use Support Announces Darren Verlenden as CEO and Strengthens Leadership Team for Further Growth and Global Expansion. Single Use Support, a leading provider of innovative fluid management and cold chain solutions for the biopharmaceutical industry, is ... - Pharming: Public Cash Offer to Acquire Abliva AB for $66.1m (2024-12-15)
> Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset > Abliva’s lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary ... - EQT LS Leads CHF27m Series B Extension in Noema Pharma (2024-12-11)
> Proceeds will be used to enable key late-stage clinical trial readouts for assets across several underserved neurological diseases with high unmet medical need. > EQT Life Sciences has led the extension, and joins a consortium of prominent global biotechnology... - Evotec: First Projects for Accelerator with Novo Nordisk (2024-12-11)
> Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases > LAB eN² is also expanding, a... - Muna Therapeutics: Strategic Alzheimer Alliance with GSK (2024-12-05)
> Multi-year effort leverages Muna's all-in-human MiND-MAP spatial multi-omics approach to identify and validate new drug targets and treatment pathways for Alzheimer’s disease > GSK secures option to multiple high-value, validated Alzheimer’s-relevant targe... - miDiagnostics Secures €30m Series D Led by Thermo Fisher (2024-12-04)
miDiagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will accelerate the development of a groundbreaking sterility test ... - Antag Therapeutics Closes €80m Series A Led by Versant (2024-12-04)
> Round led by Versant Ventures with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet > Entering Phase I testing for next-generation weight loss therapy by antagonizing GIPR Antag Therapeutics, a next-ge...
Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!
[LSS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top